The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease-A Record Based Cross-Sectional Study.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,316
- 试验地点
- 1
- 主要终点
- Comparison of in-hospital mortality rate of patients of liver disease admitted in April-May 2021 and April-May 2019.
研究概览
简要总结
Hospital record of the patients of liver disease admitted from April-May 2021 and April-May 2019 will be reviewed. Patients will be analyzed and compared for the demographic characteristics, severity of liver disease at time of admission and outcome in form of survival or mortality, liver transplantation rates in the two time periods and the subsequent 30 d and 90 day readmission rate.
Monitoring and assessment: Hospital records of all patients of liver disease needing admission during the April-May 2019 and 2021, but without active COVID-19 infection, will be reviewed. Patients will be analyzed and compared for the demographic characteristics, severity of liver disease at time of admission and outcome in form of survival or mortality, liver transplantation rates in the two time periods and 30 d and 90 d readmission rate.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients of liver disease requiring hospital admission
排除标准
- •Active COVID-19 infection at time of admission or acquiring during hospital stay.
结局指标
主要结局
Comparison of in-hospital mortality rate of patients of liver disease admitted in April-May 2021 and April-May 2019.
时间窗: Until discharge or death
次要结局
- Comparison of 31 to 90 days readmission rate of patients of liver disease.(Day 31-90)
- Comparison of 30 days readmission rate of patients of liver disease.(Day 30)
- Comparison of liver transplantation rates in the two time periods i.e., April-May 2021 and April-May 2019.(3 months)